Control of therapeutic monoclonal antibody glycosylation

Hills, Anna E. and Patel, A.K. and Boyd, Paul and James, David C. (1999) Control of therapeutic monoclonal antibody glycosylation. In: 16th Meeting of the European-Society-for-Animal-Cell-Technology (ESACT), Apr 25-29, 1999, Lugano, Switzerland. (The full text of this publication is not available from this repository)

The full text of this publication is not available from this repository. (Contact us about this Publication)
Official URL
http://dx.doi.org/10.1007/0-306-46875-1_58

Abstract

Protein N-glycosylation is regulated by the availability of nucleotide sugar substrates. Pels Rijcken et al.[3] have proposed that elevated cytosolic levels of UDP-N-acetylhexosamine impaired the transport of CMPNeuAc into the Golgi, which lead to decreased sialylation. Addition of glucosamine to cell culture medium has resulted in an increase in antennarity of N-glycans [4] . By manipulating the levels of nucleotide sugar precursors available to NS0 cells (by additions to the cell culture medium) a strategy for controlling product glycosylation could be devised.

Item Type: Conference or workshop item (Paper)
Subjects: Q Science
Divisions: Faculties > Science Technology and Medical Studies > School of Biosciences
Depositing User: I.T. Ekpo
Date Deposited: 20 Apr 2009 20:17
Last Modified: 07 Jul 2014 15:44
Resource URI: http://kar.kent.ac.uk/id/eprint/16849 (The current URI for this page, for reference purposes)
  • Depositors only (login required):